Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - TOTAL LIABILITIES
Total Liabilities ENTA - Enanta Pharmaceuticals, Inc.
248 M
LAST VALUE
114.08%
2 YEAR CAGR
55.41%
5 YEAR CAGR
43.36%
10 YEAR CAGR